VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Jun 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-06-01

Reporting Person: MCGLYNN MARGARET G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-01	Stock Option	$59.55	A	20000	Acquired	2022-05-31	Common Stock (20000)	Direct

Footnotes

F1: Fully vested.